title: Osteolytic lesions occur rarely in patients with B-CLL and may respond well to ibrutinib.
authors.affiliation: a Department of Haematology and Medical Oncology , University Medicine Goettingen , Goettingen , Germany ;
authors.forename: Evgenii
authors.initials: E
authors.lastname: Shumilov
authors.affiliation: a Department of Haematology and Medical Oncology , University Medicine Goettingen , Goettingen , Germany ;
authors.forename: Gerald
authors.initials: G
authors.lastname: Wulf
authors.affiliation: b Department of Pathology , University Medicine Goettingen , Goettingen , Germany ;
authors.forename: Philipp
authors.initials: P
authors.lastname: Ströbel
authors.affiliation: a Department of Haematology and Medical Oncology , University Medicine Goettingen , Goettingen , Germany ;
authors.forename: Justin
authors.initials: J
authors.lastname: Hasenkamp
authors.affiliation: c Department of Diagnostic and Interventional Radiology , University Medicine Goettingen , Goettingen , Germany ;
authors.forename: Niels
authors.initials: N
authors.lastname: Hellige
authors.affiliation: a Department of Haematology and Medical Oncology , University Medicine Goettingen , Goettingen , Germany ;
authors.forename: Annalen
authors.initials: A
authors.lastname: Bleckmann
authors.affiliation: a Department of Haematology and Medical Oncology , University Medicine Goettingen , Goettingen , Germany ;
authors.forename: Detlef
authors.initials: D
authors.lastname: Haase
authors.affiliation: a Department of Haematology and Medical Oncology , University Medicine Goettingen , Goettingen , Germany ;
authors.forename: Friederike
authors.initials: F
authors.lastname: Braulke
authors.affiliation: a Department of Haematology and Medical Oncology , University Medicine Goettingen , Goettingen , Germany ;
authors.forename: Wolfram
authors.initials: W
authors.lastname: Jung
authors.affiliation: a Department of Haematology and Medical Oncology , University Medicine Goettingen , Goettingen , Germany ;
authors.forename: Julie
authors.initials: J
authors.lastname: Schanz
authors.affiliation: d Department of Oncology and Haematology , University Cancer Center Hamburg (UCCH) , Hamburg , Germany.
authors.forename: Mascha
authors.initials: M
authors.lastname: Binder
authors.affiliation: a Department of Haematology and Medical Oncology , University Medicine Goettingen , Goettingen , Germany ;
authors.forename: Lorenz
authors.initials: L
authors.lastname: Trümper
authors.affiliation: a Department of Haematology and Medical Oncology , University Medicine Goettingen , Goettingen , Germany ;
authors.forename: Ulrike
authors.initials: U
authors.lastname: Bacher
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives; D000328:Adult; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications / Q000188:drug therapy*; D008297:Male; D010015:Osteolysis, Essential / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D010880:Piperidines; D011720:Pyrazoles / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D010880:Piperidines; D011720:Pyrazoles; D011743:Pyrimidines; C551803:ibrutinib; D000225:Adenine